SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-19-004243
Filing Date
2019-01-17
Accepted
2019-01-17 16:50:11
Documents
1
Period of Report
2019-01-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3972
  Complete submission text file 0001209191-19-004243.txt   5444
Mailing Address 301 NORTH MAIN STREET, SUITE 100 ANN ARBOR MI 48104
Business Address 301 NORTH MAIN STREET, SUITE 100 ANN ARBOR MI 48104 734-845-9000
Millendo Therapeutics, Inc. (Issuer) CIK: 0001544227 (see all company filings)

IRS No.: 451472564 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AVEXIS, INC., 2275 HALF DAY ROAD SUITE 160 BANNOCKBURN IL 60015
Business Address
Nuechterlein Carole (Reporting) CIK: 0001665133 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35890 | Film No.: 19531393